These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 29435304)

  • 1. Knockdown of microRNA-29a regulates the expression of apoptosis-related genes in MCF-7 breast carcinoma cells.
    Khamisipour G; Mansourabadi E; Naeimi B; Moazzeni A; Tahmasebi R; Hasanpour M; Mohammadi MM; Mansourabadi Z; Shamsian S
    Mol Clin Oncol; 2018 Feb; 8(2):362-369. PubMed ID: 29435304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Knockdown of microRNA-29a Changes the Expression of Heat Shock Proteins in Breast Carcinoma MCF-7 Cells.
    Choghaei E; Khamisipour G; Falahati M; Naeimi B; Mossahebi-Mohammadi M; Tahmasebi R; Hasanpour M; Shamsian S; Hashemi ZS
    Oncol Res; 2016 Jan; 23(1-2):69-78. PubMed ID: 26802653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA expression and regulation in the uterus during embryo implantation in rat.
    Xia HF; Jin XH; Cao ZF; Hu Y; Ma X
    FEBS J; 2014 Apr; 281(7):1872-91. PubMed ID: 24528955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-29, a key regulator of collagen expression in systemic sclerosis.
    Maurer B; Stanczyk J; Jüngel A; Akhmetshina A; Trenkmann M; Brock M; Kowal-Bielecka O; Gay RE; Michel BA; Distler JH; Gay S; Distler O
    Arthritis Rheum; 2010 Jun; 62(6):1733-43. PubMed ID: 20201077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of BACE1 by miR-29a/b in a cellular model of Spinocerebellar Ataxia 17.
    Roshan R; Ghosh T; Gadgil M; Pillai B
    RNA Biol; 2012 Jun; 9(6):891-9. PubMed ID: 22664922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endoplasmic reticulum stress-mediated upregulation of miR-29a enhances sensitivity to neuronal apoptosis.
    Nolan K; Walter F; Tuffy LP; Poeschel S; Gallagher R; Haunsberger S; Bray I; Stallings RL; Concannon CG; Prehn JH
    Eur J Neurosci; 2016 Mar; 43(5):640-52. PubMed ID: 26750440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-29a functions as a potential tumor suppressor through directly targeting CDC42 in non-small cell lung cancer.
    Li Y; Wang Z; Li Y; Jing R
    Oncol Lett; 2017 May; 13(5):3896-3904. PubMed ID: 28521487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-204 targets JAK2 in breast cancer and induces cell apoptosis through the STAT3/BCl-2/survivin pathway.
    Wang X; Qiu W; Zhang G; Xu S; Gao Q; Yang Z
    Int J Clin Exp Pathol; 2015; 8(5):5017-25. PubMed ID: 26191195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-218 targets survivin and regulates resistance to chemotherapeutics in breast cancer.
    Hu Y; Xu K; Yagüe E
    Breast Cancer Res Treat; 2015 Jun; 151(2):269-80. PubMed ID: 25900794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Id-1 regulates Bcl-2 and Bax expression through p53 and NF-kappaB in MCF-7 breast cancer cells.
    Kim H; Chung H; Kim HJ; Lee JY; Oh MY; Kim Y; Kong G
    Breast Cancer Res Treat; 2008 Nov; 112(2):287-96. PubMed ID: 18158619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of microRNA-29a alleviates hyperoxia-induced bronchopulmonary dysplasia in neonatal mice via upregulation of GAB1.
    Hu Y; Xie L; Yu J; Fu H; Zhou D; Liu H
    Mol Med; 2019 Dec; 26(1):3. PubMed ID: 31892308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survivin up-regulates the expression of breast cancer resistance protein (BCRP) through attenuating the suppression of p53 on NF-κB expression in MCF-7/5-FU cells.
    Wang QP; Wang Y; Wang XD; Mo XM; Gu J; Lu ZY; Pan ZL; Zhu YX
    Int J Biochem Cell Biol; 2013 Sep; 45(9):2036-44. PubMed ID: 23838170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Negative regulation of CDC42 expression and cell cycle progression by miR-29a in breast cancer.
    Zhang M; Guo W; Qian J; Wang B
    Open Med (Wars); 2016; 11(1):78-82. PubMed ID: 28352771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-1207-5p regulates the sensitivity of triple-negative breast cancer cells to Taxol treatment via the suppression of LZTS1 expression.
    Hou X; Niu Z; Liu L; Guo Q; Li H; Yang X; Zhang X
    Oncol Lett; 2019 Jan; 17(1):990-998. PubMed ID: 30655858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-590-3P suppresses cell survival and triggers breast cancer cell apoptosis via targeting sirtuin-1 and deacetylation of p53.
    Abdolvahabi Z; Nourbakhsh M; Hosseinkhani S; Hesari Z; Alipour M; Jafarzadeh M; Ghorbanhosseini SS; Seiri P; Yousefi Z; Yarahmadi S; Golpour P
    J Cell Biochem; 2019 Jun; 120(6):9356-9368. PubMed ID: 30520099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic potential of anti-miR29a in breast cancer patients with type 2 diabetes: an
    Li Z; Min L; Chen L; Hu Y; Luan W; Li C; Xiong Q; Huang K
    Transl Cancer Res; 2022 May; 11(5):1285-1296. PubMed ID: 35706821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of miR-15a on induction of apoptosis in breast cancer MCF-7 cells].
    Liu YH; Hong LQ; Yu WQ; Li XY; Zheng XY
    Zhonghua Zhong Liu Za Zhi; 2011 Nov; 33(11):827-30. PubMed ID: 22335947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-29a up-regulation in AR42J cells contributes to apoptosis via targeting TNFRSF1A gene.
    Fu Q; Qin T; Chen L; Liu CJ; Zhang X; Wang YZ; Hu MX; Chu HY; Zhang HW
    World J Gastroenterol; 2016 May; 22(20):4881-90. PubMed ID: 27239114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upregulation of miR-129-5p increases the sensitivity to Taxol through inhibiting HMGB1-mediated cell autophagy in breast cancer MCF-7 cells.
    Shi Y; Gong W; Lu L; Wang Y; Ren J
    Braz J Med Biol Res; 2019; 52(11):e8657. PubMed ID: 31664305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-16 mediates the regulation of a senescence-apoptosis switch in cutaneous T-cell and other non-Hodgkin lymphomas.
    Kitadate A; Ikeda S; Teshima K; Ito M; Toyota I; Hasunuma N; Takahashi N; Miyagaki T; Sugaya M; Tagawa H
    Oncogene; 2016 Jul; 35(28):3692-704. PubMed ID: 26640145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.